MENU
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunome (IMNM) Ownership - Who owns Immunome?

Immunome Inc is a biopharmaceutical company... Show more

Profile

Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
843.47M
P/E Ratio
N/A
Total Cash
317.32M
Projected Growth
N/A
Total Debt
4.77M
Revenue
10.94M
Risk (Beta)
2.98
Dividend Yield
N/A
Total Cash/Share
3.65
Total Debt/Equity
N/A
Revenue/Share
0.17 USD as % of share price

Fundamentals

IMNM
Capitalization
843M
P/E Ratio
N/A
Risk (Beta)
2.98
Dividend Yield
N/A
Total Cash
317M
Total Cash/Share
3.65
Total Debt
4.77M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.17%
Revenue
10.9M
ROE
N/A
Book Value
307M
P/B Ratio
3.13
Cash Flow
N/A
Earnings
-3.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
10.49
Current Revenue Per Employee
22335.88
Dividends Per Share - Security
N/A
EBITDA
-175.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-61.93
Shares Held By Institutions
812M
Shares Outstanding - Current
87M
Total Liabilities
35.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-8.757
View a ticker or compare two or three
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMNM showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com